|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Acer Therapeutics (NASDAQ: ACER) through any online brokerage.
The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by Needham on June 25, 2019. The analyst firm set a price target for 0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Acer Therapeutics (NASDAQ: ACER) is $2.57 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Acer Therapeutics.
There is no upcoming split for Acer Therapeutics.
Acer Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.